Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.6900
+0.0100 (1.47%)
May 13, 2026, 3:59 PM EST
Vaxart Market Cap
Vaxart has a market cap or net worth of $166.72 million as of May 14, 2026. Its market cap has increased by 63.36% in one year.
Market Cap
166.72M
Enterprise Value
117.90M
Revenue
255.61M
Ranking
n/a
PE Ratio
4.37
Stock Price
$0.69
Market Cap Chart
Since February 14, 2018, Vaxart's market cap has increased from 60.35M to 166.72M, an increase of 176.25%. That is a compound annual growth rate of 13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 163.77M | 97.01% |
| Dec 31, 2025 | 83.13M | -44.81% |
| Dec 31, 2024 | 150.61M | 72.95% |
| Dec 29, 2023 | 87.09M | -30.95% |
| Dec 30, 2022 | 126.12M | -83.97% |
| Dec 31, 2021 | 786.86M | 25.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 422.08M |
| CytoDyn | 412.04M |
| Silence Therapeutics | 338.67M |
| Glorywin Entertainment Group | 149.60M |
| HST Global | 138.60M |
| NDT Pharmaceuticals | 93.20M |
| BioStem Technologies | 76.31M |
| Cell Source | 57.07M |